The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum

Leonie C. P. Banning, Inez H. G. B. Ramakers*, Sebastian Koehler, Esther E. Bron, Frans R. J. Verhey, Peter Paul de Deyn, Jurgen A. H. R. Claassen, Huiberdina L. Koek, Huub A. M. Middelkoop, Wiesje M. van der Flier, Aad van der Lugt, Pauline Aalten, Alzheimer's Disease Neuroimaging Initiative, Parelsnoer Institute Neurodegenerative Diseases study group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)735-744
Number of pages10
JournalAmerican Journal of Geriatric Psychiatry
Volume28
Issue number7
DOIs
Publication statusPublished - Jul 2020

Keywords

  • Neuropsychiatric symptoms
  • biomarkers
  • neurocognitive disorders
  • mild cognitive impairment
  • Alzheimer's disease dementia
  • MILD COGNITIVE IMPAIRMENT
  • CEREBROSPINAL-FLUID BIOMARKERS
  • CSF BIOMARKERS
  • DEPRESSIVE SYMPTOMS
  • EARLY-STAGE
  • MRI
  • PREVALENCE
  • PROGRESSION
  • MODERATORS
  • MEDIATORS

Cite this